SIGNIFICANCE OF PHARMACOVIGILANCE PROGRAM IN CONTEXT OF ADVERSE DRUG REACTIONS (ADRs)

Abstract

This paper will discuss about the need for safe usage of drugs and monitoring in the perspective of Adverse Drug Reactions (ADR). The Pharmacovigilance program will emphasize on patient safety improvement by early detection and future avoidance of any negative consequences from the use of the drug. Hence, the discussion will be around the implementation of an effective regulatory system, clinical practices, and public health programs. Moreover, it will also will also evaluate the necessity of collecting sufficient data before marketing any drug, country wise evidence of adverse reactions, and the advantages of including the consumers in ADR reporting to attain the highest standard of health. The paper will also concentrate on limitations, like the challenges of recognizing the adverse events, underreporting, and quality report submission on the basis of population exposure, for emphasizing the necessity of reducing the adverse effects on the patients and improving their quality of life.